Dr. Smith is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1250 East Marshall Street
Internal Medicine
Richmond, VA 23298Phone+1 804-828-9690Fax+1 804-828-5566- Is this information wrong?
Education & Training
- University of Alabama Medical CenterInternship, Internal Medicine, 1981 - 1982
- University of Alabama School of MedicineClass of 1981
Certifications & Licensure
- VA State Medical License 1991 - 2024
- TN State Medical License 1983 - 1997
- American Board of Internal Medicine Internal Medicine
Clinical Trials
- Pain in Sickle Cell Epidemiologic Study Start of enrollment: 2001 Oct 01
- Enhancing Use of Hydroxyurea In Sickle Cell Disease Using Patient Navigators Start of enrollment: 2012 Oct 01
- A Study of SHP655 (rADAMTS13) in Sickle Cell Disease Start of enrollment: 2019 Oct 21
Roles: Principal Investigator
Publications & Presentations
PubMed
- 1 citationsThe Lives Lost to Inequities: Avertable Deaths From Neurologic Diseases in the Past Decade.Steven H Woolf, Derek A Chapman, Jong Hyung Lee, Karen C Johnston, Richard T Benson, Edwin Trevathan, Wally R Smith, Darrell J Gaskin> ;Neurology. 2023 Aug 15
- 3 citationsUse of Community-Engaged Research Approaches in Clinical Interventions for Neurologic Disorders in the United States: A Scoping Review and Future Directions for Improv...Bernadette Boden-Albala, Vida Rebello, Emily Drum, Desiree Gutierrez, Wally R Smith, Rachel A Whitmer, Derek M Griffith> ;Neurology. 2023 Aug 15
- Vaso-occlusive crisis pain intensity, frequency, and duration: which best correlates with health-related quality of life in adolescents and adults with sickle cell dis...Donna McClish, Victoria Okhomina, Angela Pascale, Cecelia Valrie, India Sisler, Anthony Villella, Wally Smith> ;Pain. 2024 Jan 1
- Join now to see all
Journal Articles
- Screening for Psychotherapeutic Medication Misuse in Primary Care Patients: Comparing Two InstrumentsWally R Smith, Sebastian T Tong, Journal of The American Board of Family Medicine
- A Phase 3 Trial of L-glutamine in Sickle Cell DiseaseRita Bellevue, Joseph L Lasky, Elliott P Vichinsky, Lewis L Hsu, Sharada Sarnaik, Lynne D Neumayr, Yutaka Niihara, Sophie Lanzkron, Ifeyinwa Osunkwo, Lance Sieger, Edu..., The New England Journal of Medicine
Abstracts/Posters
- Crizanlizumab Versus Placebo, with or without Hydroxyurea/Hydroxycarbamide, in Adolescent and Adult Patients with Sickle Cell Disease and Vaso-Occlusive Crises: A Rand...Wally R Smith, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Development and Validation of a Functional Status-Based Pain Assessment ToolWally R Smith, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Using Lean Six Sigma to Develop a Patient Centered Medical Home for Adults with Sickle Cell DiseaseWally R Smith, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Join now to see all
Lectures
- The Effect of Patient Navigators on Laboratory Parameters of Hydroxyurea Adherence in Sickle Cell Anemia: The SHIP-HU Study61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- The Effect of Patient Navigators on Laboratory Parameters of Hydroxyurea Adherence in Sickle Cell Anemia: The SHIP-HU Study61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Case Management Featuring Community Health Workers Reduces Inpatient Health Care Utilization in Adults with Sickle Cell Disease61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Join now to see all
Press Mentions
- SGLT2 Inhibitors Reduces Hospitalization for Heart Failure Regardless of Presence of DiabetesApril 11th, 2022
- Hydroxyurea-Based Treatment for Sickle Cell Anemia Previously Available for Pediatric Patients Now Approved for Use in AdultsFebruary 16th, 2022
- GBT Announces Upcoming Virtual Data Presentations at 62nd American Society of Hematology (ASH) Annual Meeting & ExpositionNovember 4th, 2020
- Join now to see all
Grant Support
- Virginia Basic And Translational Research ProgramNational Heart, Lung, And Blood Institute2009–2011
- Career Development For A Sickle Cell ScholarNational Heart, Lung, And Blood Institute2008–2011
- Administrative CoreNational Heart, Lung, And Blood Institute2008–2011
- Morphine Pharmacokinetics And Pharmacodynamics In Sickle Cell DiseaseNational Center For Research Resources2010
- Comparative Effectiveness Of Virginia Coordinated Care Versus The Traditional SAFAgency For Healthcare Research And Quality2010
- Virginia Comprehensive Sickle Cell Center-Center: Basic &Translational ResearchNational Heart, Lung, And Blood Institute2008
- Virginia Commonwealth University Sickle Cell Disease Clinical NetworkNational Heart, Lung, And Blood Institute2007–2008
- Virginia Commonwealth University Sickle Cell DiseaseNational Heart, Lung, And Blood Institute2006
- Multi-Center Study Of Hydroxyurea In Sickle Cell Anemia (MSH) Patients FollowNational Center For Research Resources2006
- Pain In Sickle Cell Epidemiology Study (PISCES)National Center For Research Resources2004
- Pain In Sickle Cell Epidemiologic StudyNational Heart, Lung, And Blood Institute2001–2003
- Multicenter Study Of Hydroxyurea 5 Years Follow-Up StudyNational Center For Research Resources1998–2001
Hospital Affiliations
- VCU Medical CenterRichmond, Virginia
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: